2D-BioPAD

Εύκαμπτη βιοπλατφόρμα γραφενίου για διάγνωση στο σημείο φροντίδας και έγκαιρη ανίχνευση και παρακολούθηση της νόσου Alzheimer

2D-BioPAD aims to introduce a fast and cost-effective, non-invasive, reliable, digitally and graphene enabled Point-of-Care (PoC) in-vitro diagnostics (IVD) system for supporting the early diagnosis and progression monitoring of Alzheimer’s Disease (AD) directly at primary healthcare settings. To achieve this, and tackle the scientific challenge, the technological and market gap of PoC IVD for AD, 2D-BioPAD leverages the unique properties of 2D materials, such as graphene and its derivatives.

2025

Sep, 29-Oct, 03, 5th project meeting & NanoBalκan Conference, Agenda, Conference Web       
Sep, 30 D6.5 Exploitation and Sustainability Plan, Draft       
Sep, 30 D6.2 Dissemination and Communication Plan and Activities, Draft       
Sep, 30 D7.3 Data Management Plan, Draft       
Sep, 01 Meeting for WP2, WP3, WP4, Minutes       
Aug, 18 Meeting for WP2, WP3, WP4, Minutes       
Jul, 21  Meeting for WP2, WP3, WP4, Minutes       
Jul, 07  Meeting for WP2, WP3, WP4, Minutes, Slides       
Jul, 01  Monthly meeting, ActionList, Minutes       
Jun, 20  Graphene Flagship Common KPIs       
Jun, 12  User and System Requirement Specifications (URS/SRS), Report        
Jun, 11  Mid-Term Review (M01-M18) Link,  Agenda, Review Report        
May, 26  GF roadmapping for MNPs       
May, 26  Meeting for WP2, WP3, WP4, Minutes       
May, 12   Meeting for WP2, WP3, WP4, Minutes       
May, 06  Monthly Meeting, ActionList, Minutes       
May, 05 Device Profile/Specifications, Draft       
Apr, 29  Webinar on Alzheimer’s biomarker testing, Link       
Apr, 28  Meeting for WP2, WP3, WP4, Link, Minutes       
Apr, 24  Publications M01-M18, 01, 02, 03, 04       
Apr, 24  Joint Clinical Workshop “Innov. Techn. for Brain Health: Diagnostics, Monitoring & Accessibility”, Agenda       
Mar, 31  T2.4 WP1 D1.1 Ethical Consideration Roadmap v1.0 Self-Assessment       
Mar, 31  T2.3 WP1 D1.1 Ethical Consideration Roadmap v1.0 Self-Assessment       
Mar, 31  D2.3 Conjugated MNPs/Aptamers Binding to AD Biomarkers evaluation, Version 1       
Mar, 31  D3.1 Functionalized graphene synthesis and ssDNA conjugation Version 1       
Mar, 24-25 4th Project Meeting, Olomouc, Czech Republic, WP2-PPT1, WP2-PPT2, WP2-PPT3, Minutes       
Feb, 17  2d-pl-advanced-characterisation-methods-workshop Register       
Feb, 17  Meeting for WP2, WP3, WP4, Link, Minutes       
Feb, 10  Webinar|EU Requirements for the Certification of MDs/IVDs under MDR/IVDR Register, Link       
Feb, 04  Monthly Meeting, Link, ActionList, Minutes       
Feb, 03  Meeting for WP2, WP3, WP4, Link, Minutes       
Jan, 30  Graphergia-How to protect an invention in Europe – European Patent, Link, Pdf       
Jan, 23  (LT) Technical Reporting Workshop  Link       
Jan, 22  (LT) Financial Reporting Workshop Link        
Jan, 20 (LT) Meeting for WP2, WP3, WP4 Link, Catrin-RCPTM, AUTh, NovapTech, CeADAR        
Jan, 07  monthly meeting, Minutes, Action List

2024

Dec, 31  D7.1 Management and Quality Plan               
Dec, 31  D6.1 Dissemination and Communication Plan and Activities, Version 1       
Dec, 09  Internal Progress Report       
Dec, 03  12th monthly meeting: Minutes, Action List       
Nov, 04   Progress reports: MNPs, Aptamers,  3rdSemester-Tasks        
Nov, 05   11th monthly meeting: Minutes, Action List        
Oct, 24-25 3rd Project meeting: Minutes       
Oct, 16   Project meeting: Overview       
Sep 2024 D2.1 Conjugated MNPs/Aptamers Design, Synthesis and Selection Version1       
Sep 2024 D5.1 Clinical Pilot Studies Initiation Package  
Jun 2024 D1.2 System Architecture Version 1       
May 2024 1st semester internal report  
Apr 2024 2nd newsletter  
Apr 2024 2nd meeting in Barcelona-Link,Minutes, WP2 
Apr 2024 D1.1 MCI to AD Biomarker Deep Dive Analysis for Early Diagnosis
Mar 2024 YouTube Video 
Mar 2024 D6.4 Exploitation and Sustainability Plan, Version1 
Jan 2024 D7.2 Data Management Plan, Version 1 
Jan 2024 1st newsletter 
Dec 2023 D7.1 Management and Quality Plan 
Dec 2023 D6.1 Dissemination and Communication Plan and Activities, Version 1  
Oct 2023 Kick-off meeting in Thessaloniki, WP2
magna-charta-logo-black